Glyphosate Policy, Legal Battles Heat Up
23 February 2026 Momentum around glyphosate is picking up following the recent Presidential Executive Order under the Defense Production Act aimed at protecting domestic production of elemental phosphorus and glyphosate.
In a statement given to AgriBusiness Global, Bayer said the order “reinforces the critical need for U.S. farmers to have access to essential, domestically produced crop protection tools such as glyphosate. We will comply with this order to produce glyphosate and elemental phosphorus.”
All eyes now turn to the U.S. Supreme Court, expected to rule in June or July on Bayer CropScience’s appeal of pending injury litigation. The decision could have wide-reaching implications for EPA label preemption and the legal framework governing federally approved crop protection products.
Meanwhile, Bayer has proposed a $7.25 billion settlement fund to address current and future Roundup claims. Industry watchers are monitoring how the Missouri court proceedings, the Supreme Court review, and potential federal supply chain policies could collectively reshape the future of glyphosate and domestic agrochemical production.
CropLife and AgriBusiness Global will continue to track these developments as the story unfolds.
Get The Newsletter Today!
